Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 15/20 | 0.48 |
| ▸ | SLC5A1 | P13866 | 9/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29616303 | 0.99 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL20190750 | 0.87 | SLC5A2 (0.55) | SLC5A2SLC5A1 | |
| SCHEMBL20190749 | 0.87 | SLC5A2 (0.55) | SLC5A2SLC5A1 | |
| SCHEMBL30034655 | 0.75 | SLC5A2 (0.47) | SLC5A2SLC5A1 | |
| SCHEMBL30207670 | 0.73 | MAOB (0.38) | SLC5A2SLC5A1 | |
| SCHEMBL20188583 | 0.71 | SLC5A2 (0.39) | SLC5A2SLC5A1 | |
| SCHEMBL29454922 | 0.70 | GAA (0.38) | — | |
| SCHEMBL4279547 | 0.68 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL20723768 | 0.68 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL20723767 | 0.68 | SLC5A2 (0.40) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295628-A1 | HIGHLY STABLE HEAVY METAL-REMOVING COMPOSITION, USE AND DOSAGE FORM THEREOF, AND PREPARATION METHOD THEREFOR | GUANGDONG JIANERSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2025-09-25 | — | — | US | disclosed |
| EP-4527382-A1 | HIGH-STABILITY HEAVY METAL REMOVING COMPOSITION, USE AND DOSAGE FORM THEREOF, AND METHOD FOR PREPARING SAME | Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. (CN) | 2025-03-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295628-A1 | HIGHLY STABLE HEAVY METAL-REMOVING COMPOSITION, USE AND DOSAGE FORM THEREOF, AND PREPARATION METHOD THEREFOR | SLC39A11, SLC39A7, SLC39A14 | SLC5A2 227/4885SLC5A1 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.